Markers in cancer of the larynx and pharynx

Clinical Otolaryngology and Allied Sciences

Volumn 25, Issue 1, 2000, Pages 9-18

  Greenman, John ^a   Homer, J J ^a   Stafford, N D ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b University of Hull ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ANGIOGENESIS; CANCER STAGING; CHROMOSOME 11Q; CHROMOSOME 3P; CHROMOSOME 8; DNA HYBRIDIZATION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LARYNX CANCER; LYMPH NODE METASTASIS; PHARYNX CANCER; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PHARYNGEAL NEOPLASMS; PLOIDIES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034011604     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2000.00339.x     Document Type: Review

References (98)

1. 1 Janot F., Klijanienko J., Russo A. et al. (1996) Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a retrospective analysis. Brit. J. Cancer 73, 531-538
2. 2 Jones A.S., Beasley N., Houghton D. et al. (1998) The effects of age on survival and other parameters in squamous cell carcinoma of the oral cavity, pharynx and larynx. Clin. Otolaryngol. 23, 51-56
3. 3 Singh B., Bhaya M., Zimbler M. et al. (1998) Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 20, 1-7
4. 4 Magnano M., Bussi M., de Stefani A. et al. (1995) Prognostic Factors Head and Neck Tumor Recurrence. Acta Otolaryngol. 115, 833-838
5. 5 Katz A.E. (1983) Immunobiological staging of patients with carcinoma of the head and neck. Laryngoscope 93, 445-463
6. 6 Wolf G.T., Hudson J.L., Peterson K.A. et al. (1986) Lymphocyte subpopulations infiltating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis. Otolaryngol. Head Neck Surg. 95, 142-152
7. 7 Goldsmith M.M., Cresson D.H. & Askin F.B. (1987) The prognostic significance of stromal eosinophilia in head and neck cancer. Otolaryngol. Head Neck Surg. 96, 319-324
8. 8 Thompson A.C., Bradley P.J. & Griffin N.R. (1994) Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx. Am. J. Surg. 168, 469-471
9. 9 Esteban F., Redondon M., Delgado M. et al. (1996) MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up. Br. J. Cancer 74, 1801-1804
10. 10 Brookes G.B. & Clifford P. (1981) Nutritional status and general immune competence in patients with head and neck cancer. J. Roy Soc. Med. 74, 132-139
11. 11 Lopez M.J., Robinson P., Madden T. et al. (1994) Nutritional support and prognosis in patients with head and neck cancer. J. Surg. Oncol. 55, 33-36
12. 12 Eilber F.R., Morton D.L. & Ketcham A.S. (1974) Immunologic abnormalities in head and neck cancer. Am. J. Surg. 128, 534-538
13. 13 Sobin L.H. (1997) TNM Classification of Malignant Tumours. UICC, 5th edn. John Wiley and Sons, New York
14. 14 Reid A.P., Robin P.E., Powell J. et al. (1991) Staging carcinoma: its value in cancer of the larynx. J. Laryngol. Otol. 105, 456-458
15. 15 Cerezo L., Millan I., Torre A. et al. (1992) Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer: a multivariate study of cases. Cancer 69, 1224-1234
16. 16 Bataini J.P., Bernier J., Brugere J. et al. (1985) Natural history of neck disease in patients with squamous cell carcinoma of oropharynx and pharyngolarynx. Radiother. Oncol. 3, 245-255
17. 17 Pradier R., Gonzalez A., Matos E. et al. (1993) Prognostic factors in laryngeal carcinoma: experience in 296 male patients. Cancer 71, 2472-2476
18. 18 Sakata K.I., Aoki Y., Karasawa K. et al. (1994) Radiation therapy in early glottic carcinoma: a uni-and multivariate analysis of prognostic factors affecting local control. Int. J. Rad. Oncol. Biol. Phys. 30, 1059-1064
19. 19 Johnson C.R., Thames H.D., Huang D.T. et al. (1995) The tumor Volume and clonogen number relationship: tumor control predictions based upon tumor Volume estimates derived from computed tomography. Int. J. Rad. Oncol. Biol. Phys. 33, 281-287
20. 20 Parmeijer F.A., Balm A.J.M., Hilgers F.J.M. et al. (1997) Variability of tumour volumes in T3 staged head and neck tumours. Head Neck 19, 6-13
21. 21 Dubben H.H., Thames H.D. & Beck-Bornholdt H.P. (1998) Tumor volume: a basic and specific response predictor in radiotherapy. Radiotherapy Oncol. 47, 167-174
22. 22 Yilmaz T., Hosal A.S., Gedikoglu G. et al. (1998) Prognostic significance of depth of invasion in cancer of the larynx. Laryngoscope 108, 764-768
23. 23 Nicolai P., Redaelli de Zinis L.O., Tomenzoli D. et al. (1997) Prognostic determinants in supraglottic carcinoma: univariate and Cox regression analysis. Head Neck 19, 323-334
24. 24 Alvi A. & Johnson J.T. (1996) Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol. Head Neck Surg. 114, 65-70
25. 25 Barzan L. & Talamini R. (1996) Analysis of prognostic factors for recurrence after neck dissection. Arch. Otolaryngol. Head Neck Surg. 122, 1299-1302
26. 26 De Carvalho MB. (1998) Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck 20, 16-21
27. 27 Pinsolle J., Pinsolle V., Majoufre C. et al. (1997) Prognostic value of histologic findings in neck dissections for squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 123, 145-148
28. 28 Zatterstrom U.K., Wennerberg J., Ewers S.B. et al. (1991) Prognostic factors in head and neck cancer: histologic grading, DNA ploidy, and nodal status. Head Neck 13, 477-487
29. 29 Kowalski L.P., Batista M.B., Santos C.R. et al. (1996) Prognostic factors in T3,N0 1 glottic and transglottic carcinoma: a multifactorial study of 221 cases treated by surgery or radiotherapy. Arch. Otolaryngol. Head Neck Surg. 122, 77-82
30. 30 Ali S., Tiwari R.M. & Snow G.B. (1985) False positive and false negative neck nodes. Head Neck 8, 78-82
31. 31 Madison M.T., Remley K.B., Latchaw R.E. et al. (1994) Radiologic diagnosis and staging of head and neck squamous cell carcinoma. Radiologic. Clinics North Am. 32, 163-181
32. 32 Gallo O., Boddi V., Bottai G.V. et al. (1995) Prognostic significance of clinically false positive cervical lymph nodes in patients with laryngeal carcinoma. Cancer 75, 1077-1083
33. 33 Wong W.L., Chavretton E.B., McGurk M. et al. (1997) A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin. Otolaryngol. 22, 209-214
34. 34 Jones A.S., Rowland N.J., Field J.K. et al. (1994) The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primarysites. Clin. Otolaryngol. 19, 63-69
35. 35 Jones A.S. & Stell P.M. (1991) Is laterality important in neck node metastases in head and neck cancer? Clin. Otolaryngol. 16, 261-265
36. 36 Wiernik G., Millard P.R. & Haybittle J.L. (1991) The predictive value of histological classification into degrees of differentiation of squamous cell carcinoma of the larynx and hypopharynx compared with the survival of patients. Histopathology 19, 411-417
37. 37 Jakobsson P.A. (1976) Histologic grading of malignancy and prognosis in glottic carcinoma of the larynx. In Workshops from the Centennial Conference on Laryngeal Cancer. pp. 847-854. Appleton-Century-Crofts, New York
38. 38 Bryne M., Jenssen N. & Boysen M. (1995) Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch. 427, 277-281
39. 39 Magnano M., Du Stefani A., Lerda W. et al. (1997) Prognostic factors of cervical lymph node metastasis in head and neck squamous cell carcinoma. Tumori 83, 922-926
40. 40 Weber P.C., Johnson J.T. & Myers E.N. (1993) Impact of bilateral neck dissection on recovery following supraglottic laryngectomy. Arch. Otolaryngol. Head Neck Surg. 119, 61-64
41. 41 Bataini J.P. (1993) Radiotherapy in N0 head and neck cancer patients. Eur. Arch. Otorhinolaryngol. 250, 442-445
42. 42 Stell P.M. (1990) Prognosis in laryngeal carcinoma: tumour factors. Clin. Otolaryngol. 15, 69-81
43. 43 Castelijns J.A., Golding R.P., Van Schaik C. et al. (1990) MR findings of cartilage invasion by laryngeal cancer: value in predicting outcome of radiation therapy. Radiology 174, 669-673
44. 44 Shvero J., Hadar T., Segal K. et al. (1994) Early glottic carcinoma involving the anterior commissure. Clin. Otolaryngol. 19, 105-108
45. 45 Rucci L., Gammarota L. & Gallo O. (1996) Carcinoma of the anterior commissure of the larynx: II. Proposal of a new staging system. Ann. Otol. Rhinol. Laryngol. 105, 391-396
46. 46 Folkman J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82, 4-6
47. 47 Potgens A.J., Westphal H.R., de Waal R.M. et al. (1995) The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis. Biol. Chem Hoppe-Seyler. 376, 57-70
48. 48 Gasparini G., Weidner N., Maluta S. et al. (1993) Intratumoral microvessel density and p53 protein: correlation with metastasis in head and neck squamous cell carcinoma. Int. J. Cancer 55, 739-744
49. 49 Klijanienko J., El-Naggar A.K., de Braud F. et al. (1995) Tumor vascularisation, mitotic index, histopathological grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 75, 1649-1656
50. 50 Shpitzer T., Chaimoff M., Gal R. et al. (1996) Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch. Otolaryngol. Head Neck Surg. 122, 865-868
51. 51 Murray J.D., Carlson G.W., McLaughlin K. et al. (1997) Tumor angiogenesis as a prognostic factor in laryngeal cancer. Am. J. Surg. 174, 523-526
52. 52 Eisma R.J., Spiro J.D. & Kreutzer D.L. (1999) Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous cell carcinoma. Larynogoscope 109, 687-693
53. 53 Dray T.G., Hardin N.J. & Sofferman R.A. (1995) Angiogenesis as a prognostic marker in early head and neck cancer. Ann. Otol. Rhinol. Laryngol. 104, 724-729
54. 54 Carrau R.L., Barnes E.L., Snyderman C.H. et al. (1995) Tumor angiogenesis as a predictor of tumor aggressiveness and metastatic potential in squamous cell carcinoma of the head and neck. Invasion Metastasis 15, 197-202
55. 55 Moriyama M., Kumagi S., Kawashiri S. et al. (1997) Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Clin. Oncology 33, 375-396
56. 56 Hegde P.U., Brenski A.C., Caldarelli D.D. et al. (1998) Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 124, 80-85
57. 57 Weidner N., Folkman J., Pozza F. et al. (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84, 1850-1851
58. 58 Uhlman D.L., Adams G., Knapp D. et al. (1996) Immunohistochemical staining for markers of future neoplastic progression in the larynx. Cancer Res. 56, 2199-2205
59. 59 Boyle J., Hakim J., Koch W. et al. (1993) The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 53, 4477-4480
60. 60 Brennan J.A., Mao L., Hruban R.H. et al. (1995) Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 332, 429-435
61. 61 Erber R., Conradt C., Homann N. et al. (1998) TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene 16, 1671-1679
62. 62 Oh Y. & Mao L. (1997) Biomarkers in head and neck carcinoma. Curr. Opinion Oncol. 9, 247-256
63. 63 Shin D.M., Lee J.S., Lippman S.M. et al. (1996) p53 Expressions: predict recurrence and second primary tumors in head and neck squamous cell carcinoma. J. Natl. Cancer Inst. 88, 519-529
64. 64 Rowley H., Roland N.J., Helliwell T.R. et al. (1998) p53 Protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival. Clin. Otolaryngol. 23, 57-62
65. 65 Gallo O., Santucci M. & Franchi A. (1997) Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions. J. Natl. Cancer Inst. 89, 1161-1163
66. 66 Clayman G.L., El-Naggar A.K., Lippman S.M. et al. (1998) Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J. Clin. Oncol. 16, 2221-2232
67. 67 Sidransky D. (1995) Molecular genetics of head and neck cancer. Curr. Opinion Oncol. 7, 229-233
68. 68 Kyomoto R., Kumazawa H., Toda Y. et al. (1997) Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expession in human head-and-neck squamous-cell carcinoma. Int. J. Cancer 74, 576-581
69. 69 Cattani P., Hohaus S., Bellacosa A. et al. (1998) Association between cyclin D1 (CCND1 gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma. Clin. Cancer Res. 4, 2585-2589
70. 70 Franchi A., Gallo O., Boddi V. et al. (1996) Prediction of occult neck metastases in laryngeal carcinoma: Role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin. Cancer Res. 2, 1801-1808
71. 71 Grandis J.R., Melhem M.F., Gooding W.E. et al. (1998) Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J. Natl. Cancer Inst. 90, 824-832
72. 72 Maurizi M., Almadori G., Ferrandina G. et al. (1996) Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br. J. Cancer 74, 1253-1257
73. 73 Barclay A.N., Brown M.H., Law S.K.A. et al. (1998) The Leucocyte Antigen Factsbook, 2nd edn, pp. 240-243. Academic Press, Harcout Brace & Company
74. 74 Spafford M.F., Koeppe J., Pan Z. et al. (1996) Correlation of tumour markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 122, 627-632
75. 75 Adams J.M. & Cory S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326
76. 76 Friedman M., Grey P., Venkatesan T.K. et al. (1997) Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann. Otol. Rhinol. Laryngol. 106, 445-450
77. 77 Jin Y.T., Kayser S., Kemp B.L. et al. (1998) The prognostic significance of the biomarkers p21 (WAF1/CIP1), p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 82, 2159-2165
78. 78 Elsheikh T.M., Silverman J.F., McCool J.W. et al. (1992) Comparative DNA analysis of solid tumours by flow cytometric and image analyses of touch imprints and flow cell suspensions. Am. J. Clin. Pathol. 98, 296-304
79. 79 Milroy C.M., Ferlito A., Devaney K.O. et al. (1997) Role of DNA measurements of head and neck tumors. Ann. Otol. Rhinol. Laryngol. 106, 801-804
80. 80 Virgilio L., Shuster M., Gollin S.M. et al. (1996) FHIT gene alterations in head and neck cancer squamous cell carcinomas. Proc. Natl. Acad. Sci. USA 93, 9770-9775
81. 81 Scholnick S.B., Haughey B.H., Sunwoo J.B. et al. (1996) Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx. J. Natl Cancer Inst. 88, 1676-1682
82. 82 Riva C., Lavieille J.P., Reyt E. et al. (1995) Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance. Eur. J. Cancer B Oral Oncol. 31B, 384-391
83. 83 Akervall J.A., Jin Y., Wennerberg J.P. et al. (1995) Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 76, 853-859
84. 84 Kallioniemi O.-P., Kallioniemi A., Piper J. et al. (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumours. Genes Chrom. Cancer 10, 231-243
85. 85 Hermsen M.A.J.A., Joenje H., Arwert F. et al. (1997) Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation. Oral Oncol. 33, 414-418
86. 86 Wolffe E., Girod S., Liehr T. et al. (1998) oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances by comparative genomic hybridisation. Oral Oncol. 34, 186-190
87. 87 Bockmühl U., Scwendel A., Dietel M. et al. (1996) Distinct patterns of chromosomal alterations in high-and low-grade head and neck squamous cell carcinoma. Cancer Res. 56, 5325-5329
88. 88 Bockmühl U., Petersen S., Schmidt S. et al. (1997) Patterns of chromosomal alterations in metastasizing and non-metastasizing primary head and neck carcinomas. Cancer Res. 57, 5213-5216
89. 89 Speicher M.R., Howe C., Crotty P. et al. (1995) Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res. 55, 1010-1013
90. 90 Stafford N.D., Ashman J.N.E., MacDonald A.E.W. et al. (1999) Genetic analysis of head and neck squamous carcinoma and surrounding mucosa. Arch. Otolaryngol. Head Neck Surg. 125, 1341-1348
91. 91 Pulkinen J.O., Penttinen M., Jalkanen M. et al. (1997) Syndecan-1: a new prognostic marker in laryngeal cancer. Acta OtoLaryngologica 117, 312-315
92. 92 McDonald J.S., Jones H., Pavelic Z.P. et al. (1994) Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck. J. Oral. Pathol. Med. 23, 2403-2408
93. 93 Gandour-Edwards R., Trock B.J., Gumerlock P. et al. (1998) Heat shock protein and p53 expression in head and neck squamous cell carcinoma. Otolaryngol. Head Neck Surg. 118, 610-615
94. 94 Gunduz M., Ayhan A., Gullu I. et al. (1997) nm23 protein expression in larynx cancer and the relationship with metasis. Eur. J. Cancer 33, 2338-2341
95. 95 Hagedorn H.G., Tubel J., Wiest I. et al. (1998) Prognostic aspects of the loss of epithelial basement membrane components in preinvasive and invasive laryngeal carcinomas. Anticancer Res. 18, 201-208.
96. 96 Maurizi M., Almadori G., Cadoni G. et al. (1996) Cathepsin D concentration in primary laryngel cancer: Correlation with clinicopathological parameters, EGFR status and prognosis. Int. J. Cancer 69, 105-109
97. 97 Roland N.J., Rowley H., Scraggs M. et al. MIB1 and involucrin expression in laryngeal and squamous carcinoma: The relationship to host and tumour factors and survival. Clin. Otolaryngol. 21, 429-438
98. 98 Weinberg R.A. (1996) How cancer arises. Sci. Amer. September, 17-30